From: Survival analysis in gastric cancer: a multi-center study among Iranian patients
Demographic Characteristics | Censored (nĀ =ā804) | Dead (nĀ =ā891) | Total (nĀ =ā1695) |
---|---|---|---|
Number Percent | Number Percent | Number Percent | |
Age (year) | |||
āā<ā60 | 397 49.4 | 390 43.8 | 787 46.4 |
āā>ā60 | 403 50.1 | 501 56.2 | 904 53.3 |
Sex | |||
āMale | 471 58.6 | 478 53.6 | 949 56 |
āFemale | 333 41.4 | 413 46.4 | 746 44 |
Marital status | |||
āUnmarried | 50 6.2 | 51 5.7 | 101 6 |
āMarried | 749 93.2 | 835 93.7 | 1584 93.5 |
Education | |||
āIlliterate | 220 27.4 | 125 14 | 345 20.4 |
āPrimary | 199 24.8 | 199 22.3 | 398 23.5 |
āUniversity | 58 7.2 | 88 9.9 | 146 8.6 |
Family history | |||
āYes | 201 25 | 263 29.5 | 464 27.4 |
āNo | 563 70 | 576 64.6 | 1139 67.2 |
BMI | |||
āĀ <ā18.5 | 92 11.4 | 112 12.6 | 204 12 |
ā18.6ā24.9 | 394 49 | 453 50.8 | 847 50 |
āĀ >ā25 | 115 14.3 | 109 12.2 | 189 11.2 |
Smoking status | |||
āYes | 326 40.5 | 431 48.4 | 757 44.7 |
āNo | 439 54.6 | 392 44 | 831 49 |
Tumor type | |||
āAdenocarcinoma | 384 47.8 | 427 47.9 | 811 47.8 |
āLymphoma | 73 9.1 | 44 4.9 | 117 6.9 |
āOther | 93 11.6 | 59 6.6 | 152 9 |
Lymph node | |||
āN1 | 139 17.3 | 136 15.3 | 275 16.2 |
āN2 | 209 26 | 233 26.2 | 442 26.1 |
āN3 | 39 6.1 | 37 4.2 | 86 5.1 |
Metastasis | |||
āYes | 168 20.9 | 401 45 | 569 33.6 |
āNo | 451 56.1 | 403 45.2 | 854 50.4 |
Treatment | |||
āSurgery | 437 54.3 | 470 52.7 | 907 53.5 |
āSurgery+ chemotherapy | 245 30.5 | 230 25.8 | 475 28 |
āChemotherapy+ radiotherapy | 122 15.2 | 191 21.5 | 313 18.5 |
Tumor size | |||
āT1 | 118 14.7 | 107 12 | 225 13.3 |
āT2 | 229 28.5 | 208 23.3 | 437 25.8 |
āT3 | 94 11.7 | 156 17.5 | 250 14.7 |
Grade | |||
āWell | 286 35.6 | 300 33.7 | 586 34.6 |
āModerate | 194 24.1 | 311 34.9 | 505 29.8 |
āPoorly | 124 15.4 | 110 12.3 | 234 13.8 |
āUndifferentiated | 165 20.5 | 126 14.1 | 291 17.2 |